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Background: Transpulmonary thermodilution (TPTD) derived parameters are used to direct fluid management
in ICU-patients. Extravascular lung water EVLW and its ratio to pulmonary blood volume (pulmonary vascular
permeability index PVPI) have been associated with mortality. In single indicator TPTD pulmonary blood volume
(PBV) is estimated to be 25% of global end-diastolic volume (GEDV). A recent study demonstrated marked overestimation
of GEDV indexed to body-surface area (BSA; GEDVI) when using a femoral central venous catheter (CVC) for indicator
injection due to the additional volume measured in the vena cava inferior. Therefore, a correction formula derived from
femoral TPTD and biometric data has been suggested. Consequence, one of the commercially available TPTD-devices
(PiCCO; Pulsion Medical Systems, Germany) requires information about CVC site. Correction of GEDVI for femoral CVC can
be assumed. However, there is no data if correction also pertains to unindexed GEDV, which is used for calculation of PBV
and PVPI. Therefore, we investigated, if also GEDV, PBV and PVPI are corrected by the new PiCCO-algorithm.
Methods: In this prospective study 110 triplicate TPTDs were performed within 30 hours in 11 adult ICU-patients
with PiCCO-monitoring and femoral CVC. We analyzed if the femoral TPTD correction formula for GEDVI was
also applied to correct GEDV. Furthermore, we compared PVPIdisplayed to PVPIcalculated which was calculated as
EVLWdisplayed/(0.25*GEDVdisplayed).
Results: Multiplication of GEDVIdisplayed by BSA resulted in GEDVcalculated which was not significantly different to
GEDVdisplayed (1459 ± 365 mL vs. 1459 ± 366 mL) suggesting that correction for femoral indicator injection also pertains to
GEDVdisplayed. However, PVPIdisplayed was significantly lower than PVPIcalculated (1.64 ± 0.57 vs. 2.27 ± 0.72; p < 0.001). In
addition to a bias of -0.64 ± 0.22 there was a percentage error of 22%. Application of the correction formula suggested
for GEDVI to PVPIdisplayed reduced the bias of PVPIdisplayed compared to EVLW/PBV from -0.64 ± 0.22 to -0.10 ± 0.05 and
the percentage error from 22% to 4%.
Conclusions: Correction for femoral CVC in the PiCCO-device pertains to both GEDVIdisplayed and GEDVdisplayed, but not to
PVPIdisplayed. To provide consistent information, PVPI should be calculated based on GEDVcorrected in case of femoral CVC.
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Appropriate fluid supply is a cornerstone of critical care.
In addition to cardiac output CO, transpulmonary ther-
modilution (TPTD) provides extravascular lung water
(EVLW) reflecting pulmonary edema and the preload
parameter global end-diastolic volume (GEDV) [1-6]. In-
creased EVLW is associated to mortality [3,7-11]. GEDV
and its changes are associated to CO [6] and algorithms
based on GEDV have been shown to improve outcome
[12]. Moreover, the relation of EVLW and pulmonary
blood volume (PBV) might be useful to differentiate the
etiology of pulmonary edema [13,14]. PBV can be deter-
mined using double-indicator TPTD technique [13]. Sin-
gle indicator TPTD is much more common in clinical
routine and estimates PBV as about 25% of GEDV [14].
EVLW/PBV-ratio has been termed pulmonary vascular
permeability index “PVPI”. Several studies demonstrated
that higher values of PVPI are associated to pulmonary
edema with increased permeability of the alveolo-capillary
barrier [14]. Increased PVPI has been found in patients
with ARDS resulting from pulmonary (e.g. pneumonia)
or secondary (e.g. sepsis) pulmonary impairment. By
contrast hydrostatic pulmonary edema due to congest-
ive heart failure usually does not result in marked in-
creases of PVPI since EVLW and PBV are increased to
a similar extent [13,14].
Although TPTD has become part of clinical routine,
several pitfalls have to be kept in mind. Two recent studies
demonstrated marked overestimation of GEDV in case ofFigure 1 Comparison of transpulmonary indicator dilution (TPTD) usi
subclavian CVC. Obviously, the distribution volume for the indicator is aug
indicator injection. This results in diminished indicator concentration and o
dilution technique GEDV is calculated as difference of the total dilution vol
blood volume PBV and extravascular lung water EVLW: GEDV = ITTV- (EVLW
PTV, which is directly derived from the thermodilution curve. Therefore, it c
VCI participating in TPTD.performing TPTD indicator injection using a femoral ven-
ous access due to the additional volume of vena cava in-
ferior (VCI) participating in TPTD [15,16]; Figure 1).
The authors suggested a correction formula for GEDV
indexed to predicted body surface area (GEDVI) based on
data derived from femoral TPTD and biometric infor-
mation. As a consequence of these data one the manu-
facturer of the PiCCO device (Pulsion Medical Systems,
Feldkirchen, Germany) implemented a new software
requiring the information about CVC site (femoral or
jugular/subclavian) and correcting GEDVI in case of
femoral injection. Although jugular and subclavian vein
access might be the preferred sites for CVC insertion,
several recent studies on catheter related bloodstream
infections have demonstrated that femoral venous ac-
cess was used in about 20 to 35% of all catheter inser-
tions [17,18]. Therefore, results of TPTD might be
substantially altered in about one third of cases without
appropriate correction.
To the best of our knowledge there are no data avail-
able if the new PiCCO algorithm also corrects un-
indexed GEDV and PVPI in case of femoral CVC.
Furthermore, data on PVPI were not investigated in both
previous papers on TPTD using a femoral CVC [15,16].
Therefore, it was the aim of our study to investigate if
in case of femoral indicator injection
– GEDV in the new PiCCO algorithm is given based
on the correction of GEDVI andng femoral central venous catheter (CVC) instead of jugular or
mented by the volume of vena cava inferior in case of femoral
verestimation of global enddiastolic volume GEDV. In single indicator
ume (intrathoracic thermovolume ITTV) minus the sum of pulmonary
+ PBV). The sum (PBV + EVLW) is thermed pulmonary thermovolume
an be assumed not to be altered by the additional dilution volume of
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pulmonary blood volume.
Methods
The study was approved by the institutional review
board (Ethikkommission der Fakultät für Medizin der
Technischen Universität München, Munich, Germany).
All patients or their legal representatives gave written
informed consent.
We prospectively performed 110 TPTDs in 11 patients
with femoral indicator injection. All patients were re-
cruited between October 2013 and January 2014.
Ten triplicate TPTDs per patient were performed with
15 mL cold saline within a total of 30 h. TPTD was per-
formed as described previously using the PiCCO-2 de-
vice (Pulsion Medical Systems, Feldkirchen, Germany)
[6,16,19] and a 5-lumen CVC (Multicath 5; Vygon; Aa-
chen, Germany). All PiCCO-2 devices were equipped
with the V3.1 algorithm requiring information about the
venous catheter site which was set to “femoral” CVC in
all patients.
Immediately after triplicate TPTD absolute and indexed
mean values were documented for GEDV, GEDVI, EVLW,
EVLWI and PVPI as displayed by the device. Parameters
displayed by the device were subscripted with “displayed”
(see Table 1).
The main purpose of the study was to investigate the
consistency of displayed values by comparing displayed
data (e.g. GEDVdisplayed, PVPIdisplayed) to the correspond-
ing values derived from calculation specified with the
subscript “calculated” (GEDVcaculated, PVPIcalculated).
If displayed and calculated values were inconsistent,
we investigated whether the inconsistency could be ex-
plained by (non-) application of the recently suggested
correction formula for the displayed values parameters










“calculated” Parameters calculated based on
parameters displayed on the monitor.
GEDVcalculated
These parameters should be consistent
with corresponding displayed values.
PVPIcalculated
“corrected” Parameters derived from correction of the
displayed values. Corrected parameters
were used for comparison to calculated
values (only used in case of inconsistency
of displayed and calculated values).
PVPIcorrected
GEDVuncorrectedshould result in a consistency of the “corrected” values
(with the subscript “corrected”) and the calculated
values.
To analyze if the femoral TPTD correction formula
for GEDVIdisplayed was only applied for GEDVIdisplayed or
if also GEDVdisplayed is corrected in case of femoral indi-
cator injection, we calculated GEDVcalculated using the
formula:
GEDVcalculated ¼ GEDVIdisplayed  BSApredicted:
Finally, GEDVdisplayed was compared to GEDVcalculated.
In a second step we analyzed, if PVPIdisplayed is calculated
based on a GEDVdisplayed corrected for femoral indicator
injection. Therefore, we compared PVPIdisplayed to PVPI-
calculated using the formula PVPIcalculated = EVLWdisplayed/
(0.25 * GEDVdisplayed).
Predicted bodyweight BWpredicted was calculated using
the formula:
Predicted bodyweight BWpredicted kg½  :
Male : 50 þ 0:91  height – 152:4ð Þ
Female : 45:5 þ 0:91  height – 152:4ð Þ
Predicted body surface area BSApredicted was calculated




  ¼ 0:007184  weight kg½ 0:425
 height cm½ 0:725
The correction formula suggested for correction of uncor-
rected femoral indicator injection derived GEDVuncorrected
is GEDVIcorrected [mL / m
2] = 0.539 * GEDVIuncorrected -
15.17 + 24.49 * CIuncorrected +2.311* BWideal [16].
Ideal bodyweight BWideal was calculated using the
formula:
Ideal bodyweightBWideal kg½  :
Male : height – 100ð Þ x 0:9
Female : height – 100ð Þ x 0:85
Correlation of GEDVcalculated and GEDVIdisplayed was an-
alyzed using Spearman correlation. Comparisons of
GEDVdisplayed vs. GEDVcalculated, PVPIdisplayed vs. PVPIcal-
culated and PVPIcorrected vs. PVPIcalculated were performed
using Wilcoxon-test for paired samples, respectively.
Bland-Altman analyses and calculation of percentage
error (PE) were used for these comparisons as described
previously [20,21]. Bland-Altman analyses were cor-
rected for repeated measurements allowing variability of
true values within each subject [22].
All analyses were performed using IBM SPSS Statistics
21 (SPSS inc., Chicago, IL, USA).
Table 2 Patients characteristics (mean ± standard
deviation; numbers and percentages)
Gender 5/11 (45%) female; 6/11 (55%)
male
Age [years] 59.9 ± 11.9
Height [cm] 171.1 ± 11.7
APACHE-II score 16 ± 6
SOFA score 6.5 ± 2.5
Actual bodyweight [kg] 72.8 ± 19.1
Predicted bodyweight [kg] 65.0 ± 12.0
Ideal bodyweight [kg] 62.5 ± 11.4









Measurements under vasopressors 34/110 (30.9%)
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Patients characteristics
Five female and six male patients were included. Patients
characteristics are shown in Table 2.
GEDVcalculated was obtained by multiplying GEDVIdisplayed
by BSApredicted. As demonstrated in Figure 2 GEDVcalculated
and GEDVdisplayed significantly correlated (r
2 = 1.0; p <
0.001) and were not significantly different (1459 ± 365 mL
vs. 1459 ± 366 mL).Figure 2 Scatter plot depicting the correlation of GEDV as displayed
product GEDVIdisplayed * predicted body surface area.This confirms that correction for femoral venous catheter
site pertains to both GEDVIdisplayed and GEDVdisplayed.
Consequently, calculation of PVPIcalculated based on
EVLWdisplayed and GEDVdisplayed should result in a PVPI-
calculated identical with PVPIdisplayed.
However, PVPIdisplayed was significantly lower than PVPI-
calculated (Figure 3; 1.64 ± 0.57 vs. 2.27 ± 0.72; p < 0.001).
In addition to a bias of -0.64 ± 0.22 Bland-Altman ana-
lysis demonstrated a percentage error of 22% and upper
and lower limits of agreement of -0.199 and -1.075
(Figure 4).
This could be explained if instead of the corrected
GEDVdisplayed an uncorrected GEDVuncorrected was used
for calculation of PBV and PVPIdisplayed.
Based on this hypothesis and also assuming that the for-
mula for femoral indicator injection suggested by our
group is used by the latest PiCCO algorithm we deter-
mined PVPIcorrected by multiplying PVPIcalculated by the
ratio GEDVuncorrected/GEDVdisplayed.
As shown in Figure 5 the bias of PVPIdisplayed.d to EVLW/
PBV could be reduced from -0.64 ± 0.22 to -0.10 ± 0.05.
Furthermore, percentage error decreased from 22% to
4% with upper and lower limits of agreement of -0.009
and -0.190 (Figure 5).
Discussion
Despite improving outcome by a number of specific and
unspecific approaches such as low tidal volume [23],
extracorporeal lung assist [24] and prone positioning
[25] ARDS still carries a high mortality of up to 65%
[23-26]. Well balanced fluid management providing ap-
propriate resuscitation [27] as well as avoiding fluidby the PiCCO-2 device (GEDVdisplayed) vs. GEDV calculated as
Figure 3 Boxplots plots comparing pulmonary vascular permeability index PVPI as displayed by the PiCCO-2 device (PVPIdisplayed) vs.
PVPI calculated as ratio of EVLW/PBV (extravascular lung water/pulmonary blood volume) vs. PVPI corrected using the formula
suggested for correction of femoral indicator injection derived GEDV [16]: GEDVIcorrected [mL / m
2] = 0.539 * GEDVIuncorrected - 15.17 +
24.49 * CIuncorrected 2.311* BWideal. Assuming that PVPIdisplayed was calculated based on GEDV and PBV not corrected for femoral injection,
PVPIcorrected was calculated by multiplying PVPIdisplayed with the ratio 0.25*GEDVuncorrected/0.25*GEDVcorrected.
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proach to improve outcome in ARDS. EVLW has been
validated as a significant predictor of outcome in ARDS
[3,7-11]. However, with regard to fluid management it is
important, if increased EVLW derives from inflamma-
tory capillary leakage of the lungs or from general fluid
overload and congestive heart failure. Relating EVLW to
pulmonary blood volume, PVPI has been demonstratedFigure 4 Bland Altman plot comparing pulmonary vascular permeabi
vs. PVPI calculated as ratio of EVLW/PBV (extravascular lung water/puto discriminate inflammatory from congestive pulmonary
failure [13,14]. Therefore, combined use of EVLW and
PVPI has been suggested to specify therapy in acute pul-
monary failure. However, there are a number of studies
suggesting pitfalls in using these parameters derived from
TPTD: Due to its current indexation solely to bodyweight
EVLWI might be inappropriately lowered in obese pa-
tients. Therefore, weight correction formulas [19] andlity index PVPI as displayed by the PiCCO-2 device (PVPIdisplayed)
lmonary blood volume).
Figure 5 Bland Altman plot comparing pulmonary vascular permeability index PVPIdisplayed corrected by the correction formula for
femoral indicator injection (PVPIcorrected; see Figure 3) vs. PVPI calculated as ratio of EVLW/PBV (extravascular lung water/pulmonary
blood volume).
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to improve usefulness of EVLWI. Furthermore, femoral
central vein access for TPTD indicator injection inappro-
priately increases GEDV(I) [15,16]. Therefore, a correction
formula for GEDVI in case of femoral CVC has been sug-
gested [16]. Requirement of information about the CVCFigure 6 Algorithm for the calculation of GEDV, GEDVI, PBV and PVPI
suggested using GEDVcorrected and PBVcorrected for the calculation of Psite in the last PiCCO algorithm suggests that some kind
of correction for femoral CVC is provided. Due to the as-
sumption that PBV is 25% of GEDV in single indicator
TPTD [6,12], overestimation of GEDV in femoral indica-
tor TPTD indicator injection also pertains to PVPI.
However, no information is available,as displayed by the PiCCO-2 software V 3.1 (PVPIdisplayed) and as
VPIcalculated. Values not displayed are shaded.
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applies only to GEDVI or also to GEDV
– if this correction is similar to the formula suggested
by Saugel et al. [16] and
– if PVPIdisplayed is based on PBV and GEDV derived
from the correction formula suggested by our group.
Therefore, we performed a prospective study in patients
with femoral CVC access showing the following main re-
sults that are graphically summarized in Figure 6.
GEDVdisplayed is corrected to the same degree as
GEDVIdisplayed.
However, PVPIdisplayed provided by the PiCCO-device
is significantly lower than PVPIcalculated derived by divid-
ing EVLWdisplayed by 0.25*GEDVdisplayed. This suggests
the use of uncorrected GEDV and uncorrected PBV for
the PVPI displayed by the device.
This assumption is supported by PVPIcorrected
values nearly identical to PVPIcalculated when correcting
PVPIdisplayed using the correction formula.Practical implications
Our data strongly suggest that the correction formula for
GEDVI in case of femoral CVC indicator injection should
be also applied for the calculation of PVPI. Otherwise,
PVPI would remain to be artificially lowered in case of
femoral CVC which also would result in different PVPI
threshold for inflammatory vs. congestive pulmonary
impairment.Limitations of the study
Despite conclusive results with high statistical significance
this is a single centre study with a limited number of pa-
tients and TPTD measurements. Furthermore, we have to
admit that our explanations for this inconsistency are in
part speculative: Although correction of PVPIdisplayed by
our formula results in PVPIcorrected close to PVPIdisplayed,
the hypothesis of a “neglect” of correction of PBV has to
be proven by a confirmatory study. Future studies should
verify the practical implications, e.g. showing improved as-
sociation of PVPI with outcome when applying the cor-
rection formula also for PBV and PVPI. Furthermore, our
findings could be confirmed by comparing PVPI derived
from femoral and jugular indicator injection in patients
with both femoral and jugular CVC.
Finally, these findings pertain to the PiCCO-2 device
with the V3.1 algorithm. To the best of our knowledge,
there is only one other device providing PVPI which is the
Edwards EV 1000 VolumeView (Edwards Lifesciences; Ir-
vine, CA, USA). Despite some minor modifications of the
thermodilution analysis this device is comparable to the
PiCCO. However, the EV-1000 does not require informa-
tion about the CVC site. This suggests that the devicedoes neither correct GEDV(I) nor PVPI in case of femoral
CVC site.
Conclusion
This study suggests that the V3.1 software of the PiCCO-
device corrects GEDVI and GEDV for TPTD indicator
injection based on a correction formula similar to the cor-
rection recently suggested [16]. However, correction of
GEDV(I) does not pertain to PVPI which is contradictory
to the definition of PVPI and results in a substantial
underestimation of PVPI. To make PVPI values derived
from jugular and femoral indicator injection comparable,
corrected GEDV and PBV should be used for calculation
of PVPI in case of femoral CVC.
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